A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : XLP / X-linked lymphoproliferative disease

[Related PubMed/MEDLINE]
Total Number of Papers: 226
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   XLP  (>> Co-occurring Abbreviation)
Long Form:   X-linked lymphoproliferative disease
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 X-Linked Lymphoproliferative Disease in Latvia: A Report of Two Clinically Distinct Cases. ---
2020 X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic. EBV, HLH, IBD
2019 2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in systemic lupus erythematosus and cancer. MM, SLAM, SLE
2019 Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants. CAEBV, EBV, HLH, LPDs, NK, PIDs
2018 Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor. PD-1, SAP
2018 Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing. EBV, LPD, NGS, PCR, PIDs
2018 X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective. EBV, HLH, XLP-1
2017 2B4-SAP signaling is required for the priming of naive CD8+ T cells by antigen-expressing B cells and B lymphoma cells. APC, EBV, SAP, SLAM, TCR
2017 Dissection of SAP-dependent and SAP-independent SLAM family signaling in NKT cell development and humoral immunity. SFRs, SLAM
10  2017 Progressive reduction of circulating B lymphocytes in patients with X-linked lymphoproliferative disease (XLP). ---
11  2016 Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature. AA, EBV, FIM, HLH, HSCT
12  2015 A female patient with incomplete hemophagocytic lymphohistiocytosis caused by a heterozygous XIAP mutation associated with non-random X-chromosome inactivation skewed towards the wild-type XIAP allele. HLH, XCI
13  2015 Cerebral Vasculitis in X-linked Lymphoproliferative Disease Cured by Matched Unrelated Cord Blood Transplant. HHV-7
14  2015 Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden. FHL, GS2, HLH
15  2015 Study of SH2D1A gene mutation in paediatric patients with B-cell lymphoma. ---
16  2014 Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease. EBV, HLH
17  2014 Expansion of murine gammaherpesvirus latently infected B cells requires T follicular help. EBV, FIM, MHV-68, SAP, Tfh
18  2014 Extremely elevated cerebrospinal fluid protein levels in a child with neurologic symptoms: beware of haemophagocytic lymphohistiocytosis. CSF, HLH
19  2014 Hematopoietic stem cell transplantation conditioning with use of rituximab in EBV related lymphoproliferative disorders. HSCT, ITK
20  2014 Identification of a new isoform of the murine Sh2d1a gene and its functional implications. SH, SLAM
21  2014 Lentiviral vectors for the treatment of primary immunodeficiencies. CGD, HSC, IPEX, LVVs, PIDs, SIN, WAS
22  2014 Signaling lymphocytic activation molecule (SLAM)/SLAM-associated protein pathway regulates human B-cell tolerance. SLAM, Treg
23  2014 Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. HLH, IL, XIAP
24  2014 The value of DNA storage and pedigree analysis in rare diseases: a 17-year-old boy with X-linked lymphoproliferative disease (XLP) caused by a de novo SH2D1A mutation. ---
25  2014 XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP. ---
26  2013 Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome. EBV, FIM, HLH
27  2013 Clinical phenotype and functional analysis of a rare XIAP/BIRC4 mutation. ---
28  2013 Flow cytometric measurement of SLAM-associated protein and X-linked inhibitor of apoptosis. SAP, XIAP
29  2013 Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms. ---
30  2013 Lymphoma and cerebral vasculitis in association with X-linked lymphoproliferative disease. ---
31  2013 NK cell cytotoxicity mediated by 2B4 and NTB-A is dependent on SAP acting downstream of receptor phosphorylation. EAT-2, NK, SAP, SLAM
32  2013 SAP modulates B cell functions in a genetic background-dependent manner. SAP
33  2013 X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. HLH, XIAP
34  2012 Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2. EBV, EBV-HLH, HLH, SAP, XIAP, XLP-1
35  2012 Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis. HSCT
36  2012 Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus. EBV, SAP
37  2012 HHV-8-related hemophagocytic lymphohistiocytosis in a boy with XLP phenotype. EBV, HHV-8, HLH
38  2012 p53 contributes to T cell homeostasis through the induction of pro-apoptotic SAP. ---
39  2012 SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis. HLH, SAP
40  2012 SAP expression in invariant NKT cells is required for cognate help to support B-cell responses. alpha-GalCer, NKT, SLAM
41  2011 Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). HLH, XLP-1, XLP-2
42  2011 Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry. EBV, HLH, SAP
43  2011 Langerhans cell histiocytosis, a new clinical phenotype of x-linked lymphoproliferative disease? LCH
44  2011 Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. ---
45  2011 The role of SAP and SLAM family molecules in the humoral immune response. SAP, SLAM
46  2011 X-Linked Lymphoproliferative Syndrome and Common Variable Immunodeficiency May Not Be Differentiated by SH2D1A and XIAP/BIRC4 Genes Sequence Analysis. ---
47  2011 X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. EBV, SLAM, XIAP
48  2011 [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives]. EBV, FIM, MODS
49  2010 An atypical case of X-linked lymphoproliferative disease revealed as a late cerebral lymphoma. ---
50  2010 Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development. BL, EBV
51  2010 Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets. EBV, LCLs, NTBA, SLAM
52  2010 The power and the promise of restimulation-induced cell death in human immune diseases. RICD
53  2010 To B or not to B. EBV
54  2010 XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. HLH, XIAP
55  2009 A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency. HCT, HLH, XIAP
56  2009 Hemophagocytic lymphohistiocytosis in a patient with x-linked lymphoproliferative disease. HLH, NK, SAP
57  2009 Increased lymphocyte viability after non-stimulated peripheral blood mononuclear cell (PBMC) culture in patients with X-linked lymphoproliferative disease (XLP). PBMC
58  2009 Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection. EBV
59  2009 Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. iNKT cells, TCR, XIAP
60  2009 Phenotypic differences between mice deficient in XIAP and SAP, two factors targeted in X-linked lymphoproliferative syndrome (XLP). XIAP
61  2009 Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. NTB-A, RICD, SAP
62  2009 SAP binds to CD22 and regulates B cell inhibitory signaling and calcium flux. SLAM
63  2009 The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease. AICD, EBV, IM, LCL, VCP
64  2009 The XLP syndrome protein SAP interacts with SH3 proteins to regulate T cell signaling and proliferation. TCR
65  2009 To the genesis of Burkitt lymphoma: regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes. BLs, EBV
66  2008 Chronic active gastritis in X-linked lymphoproliferative disease. EBV
67  2008 Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+CD27+ B cells harbor the virus in X-linked lymphoproliferative disease patients. EBV, EBV-AHS, Ig
68  2008 Sequence analysis of BIRC4/XIAP in male patients with common variable immunodeficiency. CVID
69  2008 X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses. NKT
70  2007 Factors involved in the generation of memory CD8+ T cells in patients with X-linked lymphoproliferative disease (XLP). AIM, EBV
71  2007 Familial and acquired hemophagocytic lymphohistiocytosis. CHS 1, CTL, GS 2, HLH, NK
72  2007 Natural killer T cells and X-linked lymphoproliferative syndrome. XIAP
73  2007 Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. SAP
74  2007 Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease. EBV
75  2007 [An X-linked lymphoproliferative syndrome (XLP) caused by mutations in the inhibitor-of-apoptosis gene XIAP]. ---
76  2007 [Clinical and gene research of X-linked lymphoproliferative disease in a Chinese family]. ---
77  2006 Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells. ARL, EBV, LCLs, PTLD, SOT
78  2006 Diffuse CNS vasculopathy with chronic Epstein-Barr virus infection in X-linked lymphoproliferative disease. CNS
79  2006 Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. ---
80  2006 Fine-tuning of immune responses by SLAM-related receptors. SAP, SLAM
81  2006 Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease. EBV, SAP
82  2006 Missense mutations in SH2D1A identified in patients with X-linked lymphoproliferative disease differentially affect the expression and function of SAP. SLAM
83  2006 SAP deficiency results in a striking alteration of the protein profile in activated CD4 T cells. SAP
84  2006 Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. GCs
85  2006 The CD2 family of natural killer cell receptors. NK
86  2006 The X-linked lymphoproliferative disease gene product SAP associates with PAK-interacting exchange factor and participates in T cell activation. GEF, NFAT, PIX, SH2, SLAM
87  2006 XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. EBV, NKT cells, SLAM, TCR, TRAIL-R
88  2006 [Case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain]. ---
89  2005 Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature. allo-SCT
90  2005 Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. EBV
91  2005 Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. EBV, HLH, HPS, IFN-gamma, LMP1, NF-kappaB, SLAM, TRAF
92  2005 Familial and acquired hemophagocytic lymphohistiocytosis. CHS, CNS, CTL, GS, HLH, NK
93  2005 Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. ICOS, SLAM-associated
94  2005 Impaired Ig class switch in mice deficient for the X-linked lymphoproliferative disease gene Sap. IgE, IL-4, LPS, NK, NKT, SLAM
95  2005 Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. NK, SLAM
96  2005 Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). ITSM, NK, SAP
97  2005 Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. EBV-HLH, NK
98  2005 Regulation of NKT cell development by SAP, the protein defective in XLP. alphaGC, NK
99  2005 Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. SAP, SAPKO, SH2D1A
100  2005 The impact of telomere erosion on memory CD8+ T cells in patients with X-linked lymphoproliferative syndrome. EBV, SLAM